FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Malaria | Vaccine

Glaxo promises "sustainable" malaria vax price

Glaxo's Andrew Witty says he'll price the company's new malaria vaccine just over cost. And any profits, he pledges, will be plowed back into research. Analysts say that more than $500 million has been spent advancing the new vaccine through the pipeline. Report

Twitter   Facebook   LinkedIn   StumbleUpon  
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about Malaria   Vaccine  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.